Article
Norcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition.
PloS one - 1 Jan 2013
Li Ying, Sun Yan, Liu Fuyou, Sun Lin, Li Jun, Duan Shaobin, Liu Hong, Peng Youming, Xiao Li, Liu Yuping, Xi Yiyun, You Yanhua, Li Hua, Wang Min, Wang Shuai, Hou Tao
Abstract excerpt
Epithelial-mesenchymal transition (EMT) is thought to contribute to the progression of renal tubulointerstitial fibrosis. Norcantharidin (NCTD) is a promising agent for inhibiting renal interstitial fibrosis. However, the molecular mechanisms of NCTD are unclear. In this study, a unilateral ureteral obstruction (UUO) rat model was established and treated with intraperitoneal NCTD (0.1 mg/kg/day). The UUO rats...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
